nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—Alvimopan—OPRM1—nicotine dependence	0.0371	1	CrCbGaD
Indinavir—Aphthous stomatitis—Varenicline—nicotine dependence	0.0313	0.0396	CcSEcCtD
Indinavir—Myositis—Varenicline—nicotine dependence	0.03	0.0379	CcSEcCtD
Indinavir—Night sweats—Varenicline—nicotine dependence	0.0272	0.0344	CcSEcCtD
Indinavir—Urine abnormality—Varenicline—nicotine dependence	0.0265	0.0336	CcSEcCtD
Indinavir—Urine analysis abnormal—Varenicline—nicotine dependence	0.025	0.0316	CcSEcCtD
Indinavir—Platelet count decreased—Varenicline—nicotine dependence	0.0247	0.0312	CcSEcCtD
Indinavir—Fungal infection—Varenicline—nicotine dependence	0.019	0.0241	CcSEcCtD
Indinavir—Gingivitis—Varenicline—nicotine dependence	0.0187	0.0237	CcSEcCtD
Indinavir—Nephrolithiasis—Varenicline—nicotine dependence	0.0183	0.0231	CcSEcCtD
Indinavir—Nocturia—Varenicline—nicotine dependence	0.0158	0.02	CcSEcCtD
Indinavir—Musculoskeletal pain—Varenicline—nicotine dependence	0.0149	0.0188	CcSEcCtD
Indinavir—Eructation—Varenicline—nicotine dependence	0.0144	0.0183	CcSEcCtD
Indinavir—Influenza like illness—Varenicline—nicotine dependence	0.0143	0.018	CcSEcCtD
Indinavir—Lymphadenopathy—Varenicline—nicotine dependence	0.0125	0.0158	CcSEcCtD
Indinavir—Sleep disorder—Varenicline—nicotine dependence	0.0123	0.0156	CcSEcCtD
Indinavir—Diabetes mellitus—Varenicline—nicotine dependence	0.0123	0.0155	CcSEcCtD
Indinavir—Eye pain—Varenicline—nicotine dependence	0.0118	0.0149	CcSEcCtD
Indinavir—Renal failure acute—Varenicline—nicotine dependence	0.0116	0.0146	CcSEcCtD
Indinavir—Increased appetite—Varenicline—nicotine dependence	0.0114	0.0144	CcSEcCtD
Indinavir—CYP3A7—Xenobiotics—CYP2A7—nicotine dependence	0.0109	0.0635	CbGpPWpGaD
Indinavir—CYP2C19—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00984	0.0572	CbGpPWpGaD
Indinavir—Dry skin—Varenicline—nicotine dependence	0.00978	0.0124	CcSEcCtD
Indinavir—Cramp muscle—Varenicline—nicotine dependence	0.00961	0.0121	CcSEcCtD
Indinavir—Gastritis—Varenicline—nicotine dependence	0.00944	0.0119	CcSEcCtD
Indinavir—Abdominal distension—Varenicline—nicotine dependence	0.00928	0.0117	CcSEcCtD
Indinavir—CYP2D6—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00905	0.0526	CbGpPWpGaD
Indinavir—Angina pectoris—Varenicline—nicotine dependence	0.00898	0.0114	CcSEcCtD
Indinavir—CYP2C9—CYP2E1 reactions—CYP2A7—nicotine dependence	0.00897	0.0522	CbGpPWpGaD
Indinavir—Pollakiuria—Varenicline—nicotine dependence	0.00852	0.0108	CcSEcCtD
Indinavir—Weight increased—Varenicline—nicotine dependence	0.00839	0.0106	CcSEcCtD
Indinavir—Hyperglycaemia—Varenicline—nicotine dependence	0.00832	0.0105	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Varenicline—nicotine dependence	0.00815	0.0103	CcSEcCtD
Indinavir—Acute coronary syndrome—Varenicline—nicotine dependence	0.00811	0.0102	CcSEcCtD
Indinavir—Myocardial infarction—Varenicline—nicotine dependence	0.00806	0.0102	CcSEcCtD
Indinavir—CYP3A5—Xenobiotics—CYP2A7—nicotine dependence	0.00789	0.0459	CbGpPWpGaD
Indinavir—Hepatobiliary disease—Varenicline—nicotine dependence	0.00778	0.00983	CcSEcCtD
Indinavir—Sinusitis—Varenicline—nicotine dependence	0.00771	0.00975	CcSEcCtD
Indinavir—Hypoaesthesia—Varenicline—nicotine dependence	0.00734	0.00929	CcSEcCtD
Indinavir—Urinary tract disorder—Varenicline—nicotine dependence	0.00729	0.00922	CcSEcCtD
Indinavir—Connective tissue disorder—Varenicline—nicotine dependence	0.00725	0.00917	CcSEcCtD
Indinavir—Urethral disorder—Varenicline—nicotine dependence	0.00724	0.00915	CcSEcCtD
Indinavir—CYP2D6—Fatty acids—CYP2A7—nicotine dependence	0.00706	0.0411	CbGpPWpGaD
Indinavir—Erythema multiforme—Varenicline—nicotine dependence	0.00698	0.00882	CcSEcCtD
Indinavir—Immune system disorder—Varenicline—nicotine dependence	0.00667	0.00843	CcSEcCtD
Indinavir—Chills—Varenicline—nicotine dependence	0.00662	0.00837	CcSEcCtD
Indinavir—Malnutrition—Varenicline—nicotine dependence	0.00643	0.00812	CcSEcCtD
Indinavir—Flatulence—Varenicline—nicotine dependence	0.00633	0.00801	CcSEcCtD
Indinavir—Dysgeusia—Varenicline—nicotine dependence	0.00629	0.00796	CcSEcCtD
Indinavir—Back pain—Varenicline—nicotine dependence	0.00622	0.00786	CcSEcCtD
Indinavir—Muscle spasms—Varenicline—nicotine dependence	0.00618	0.00781	CcSEcCtD
Indinavir—CYP2C19—Xenobiotics—CYP2A7—nicotine dependence	0.0061	0.0355	CbGpPWpGaD
Indinavir—Vision blurred—Varenicline—nicotine dependence	0.00606	0.00766	CcSEcCtD
Indinavir—Tremor—Varenicline—nicotine dependence	0.00602	0.00761	CcSEcCtD
Indinavir—Ill-defined disorder—Varenicline—nicotine dependence	0.00596	0.00754	CcSEcCtD
Indinavir—Anaemia—Varenicline—nicotine dependence	0.00594	0.00751	CcSEcCtD
Indinavir—Agitation—Varenicline—nicotine dependence	0.00591	0.00747	CcSEcCtD
Indinavir—Angioedema—Varenicline—nicotine dependence	0.00587	0.00742	CcSEcCtD
Indinavir—Malaise—Varenicline—nicotine dependence	0.00579	0.00733	CcSEcCtD
Indinavir—Vertigo—Varenicline—nicotine dependence	0.00577	0.0073	CcSEcCtD
Indinavir—Syncope—Varenicline—nicotine dependence	0.00576	0.00729	CcSEcCtD
Indinavir—Palpitations—Varenicline—nicotine dependence	0.00568	0.00718	CcSEcCtD
Indinavir—Loss of consciousness—Varenicline—nicotine dependence	0.00565	0.00714	CcSEcCtD
Indinavir—CYP2D6—Xenobiotics—CYP2A7—nicotine dependence	0.00561	0.0326	CbGpPWpGaD
Indinavir—Cough—Varenicline—nicotine dependence	0.00561	0.00709	CcSEcCtD
Indinavir—CYP2C9—Xenobiotics—CYP2A7—nicotine dependence	0.00556	0.0323	CbGpPWpGaD
Indinavir—Chest pain—Varenicline—nicotine dependence	0.00547	0.00692	CcSEcCtD
Indinavir—Arthralgia—Varenicline—nicotine dependence	0.00547	0.00692	CcSEcCtD
Indinavir—Myalgia—Varenicline—nicotine dependence	0.00547	0.00692	CcSEcCtD
Indinavir—Anxiety—Varenicline—nicotine dependence	0.00545	0.00689	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Varenicline—nicotine dependence	0.00543	0.00687	CcSEcCtD
Indinavir—Discomfort—Varenicline—nicotine dependence	0.00541	0.00683	CcSEcCtD
Indinavir—Dry mouth—Varenicline—nicotine dependence	0.00535	0.00676	CcSEcCtD
Indinavir—Oedema—Varenicline—nicotine dependence	0.00524	0.00663	CcSEcCtD
Indinavir—Shock—Varenicline—nicotine dependence	0.00516	0.00652	CcSEcCtD
Indinavir—Nervous system disorder—Varenicline—nicotine dependence	0.00514	0.0065	CcSEcCtD
Indinavir—Thrombocytopenia—Varenicline—nicotine dependence	0.00513	0.00649	CcSEcCtD
Indinavir—Skin disorder—Varenicline—nicotine dependence	0.00509	0.00644	CcSEcCtD
Indinavir—Hyperhidrosis—Varenicline—nicotine dependence	0.00507	0.00641	CcSEcCtD
Indinavir—Anorexia—Varenicline—nicotine dependence	0.005	0.00632	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00478	0.00604	CcSEcCtD
Indinavir—Insomnia—Varenicline—nicotine dependence	0.00474	0.006	CcSEcCtD
Indinavir—Dyspnoea—Varenicline—nicotine dependence	0.00468	0.00591	CcSEcCtD
Indinavir—Somnolence—Varenicline—nicotine dependence	0.00466	0.00589	CcSEcCtD
Indinavir—Dyspepsia—Varenicline—nicotine dependence	0.00462	0.00584	CcSEcCtD
Indinavir—Decreased appetite—Varenicline—nicotine dependence	0.00456	0.00576	CcSEcCtD
Indinavir—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00453	0.0264	CbGpPWpGaD
Indinavir—Gastrointestinal disorder—Varenicline—nicotine dependence	0.00453	0.00572	CcSEcCtD
Indinavir—Fatigue—Varenicline—nicotine dependence	0.00452	0.00572	CcSEcCtD
Indinavir—Constipation—Varenicline—nicotine dependence	0.00448	0.00567	CcSEcCtD
Indinavir—Pain—Varenicline—nicotine dependence	0.00448	0.00567	CcSEcCtD
Indinavir—CYP3A7—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00447	0.026	CbGpPWpGaD
Indinavir—Feeling abnormal—Varenicline—nicotine dependence	0.00432	0.00546	CcSEcCtD
Indinavir—Gastrointestinal pain—Varenicline—nicotine dependence	0.00429	0.00542	CcSEcCtD
Indinavir—Urticaria—Varenicline—nicotine dependence	0.00417	0.00527	CcSEcCtD
Indinavir—Body temperature increased—Varenicline—nicotine dependence	0.00415	0.00524	CcSEcCtD
Indinavir—Abdominal pain—Varenicline—nicotine dependence	0.00415	0.00524	CcSEcCtD
Indinavir—Hypersensitivity—Varenicline—nicotine dependence	0.00386	0.00489	CcSEcCtD
Indinavir—Asthenia—Varenicline—nicotine dependence	0.00376	0.00476	CcSEcCtD
Indinavir—Pruritus—Varenicline—nicotine dependence	0.00371	0.00469	CcSEcCtD
Indinavir—CYP3A7—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00367	0.0214	CbGpPWpGaD
Indinavir—CYP3A4—Xenobiotics—CYP2A7—nicotine dependence	0.00367	0.0213	CbGpPWpGaD
Indinavir—Diarrhoea—Varenicline—nicotine dependence	0.00359	0.00454	CcSEcCtD
Indinavir—Dizziness—Varenicline—nicotine dependence	0.00347	0.00438	CcSEcCtD
Indinavir—Vomiting—Varenicline—nicotine dependence	0.00333	0.00422	CcSEcCtD
Indinavir—Rash—Varenicline—nicotine dependence	0.00331	0.00418	CcSEcCtD
Indinavir—Dermatitis—Varenicline—nicotine dependence	0.0033	0.00418	CcSEcCtD
Indinavir—Headache—Varenicline—nicotine dependence	0.00329	0.00415	CcSEcCtD
Indinavir—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00328	0.0191	CbGpPWpGaD
Indinavir—CYP3A5—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00323	0.0188	CbGpPWpGaD
Indinavir—Nausea—Varenicline—nicotine dependence	0.00312	0.00394	CcSEcCtD
Indinavir—CYP3A5—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00266	0.0154	CbGpPWpGaD
Indinavir—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00253	0.0147	CbGpPWpGaD
Indinavir—CYP2C19—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0025	0.0145	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00235	0.0137	CbGpPWpGaD
Indinavir—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00233	0.0135	CbGpPWpGaD
Indinavir—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00231	0.0134	CbGpPWpGaD
Indinavir—CYP2D6—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0023	0.0134	CbGpPWpGaD
Indinavir—CYP2C9—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00228	0.0133	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00223	0.0129	CbGpPWpGaD
Indinavir—CYP3A7—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00207	0.012	CbGpPWpGaD
Indinavir—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00205	0.0119	CbGpPWpGaD
Indinavir—CYP3A7—Biological oxidations—CYP2A7—nicotine dependence	0.00195	0.0114	CbGpPWpGaD
Indinavir—CYP3A7—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00192	0.0112	CbGpPWpGaD
Indinavir—CYP2D6—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00189	0.011	CbGpPWpGaD
Indinavir—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00187	0.0109	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.0018	0.0105	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.00171	0.00992	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00161	0.00936	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00154	0.00898	CbGpPWpGaD
Indinavir—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00152	0.00886	CbGpPWpGaD
Indinavir—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.0015	0.00874	CbGpPWpGaD
Indinavir—CYP3A5—Metapathway biotransformation—AKR1B10—nicotine dependence	0.0015	0.0087	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00143	0.00834	CbGpPWpGaD
Indinavir—CYP3A5—Biological oxidations—CYP2A7—nicotine dependence	0.00141	0.0082	CbGpPWpGaD
Indinavir—CYP3A5—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00139	0.00809	CbGpPWpGaD
Indinavir—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00123	0.00718	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.00123	0.00717	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00118	0.00688	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00117	0.0068	CbGpPWpGaD
Indinavir—CYP2C19—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00116	0.00673	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.0011	0.00639	CbGpPWpGaD
Indinavir—CYP2C19—Biological oxidations—CYP2A7—nicotine dependence	0.00109	0.00634	CbGpPWpGaD
Indinavir—CYP2C19—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00108	0.00626	CbGpPWpGaD
Indinavir—CYP2D6—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00106	0.00619	CbGpPWpGaD
Indinavir—CYP2C9—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00106	0.00614	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00103	0.00599	CbGpPWpGaD
Indinavir—CYP2D6—Biological oxidations—CYP2A7—nicotine dependence	0.001	0.00583	CbGpPWpGaD
Indinavir—CYP2C9—Biological oxidations—CYP2A7—nicotine dependence	0.000995	0.00578	CbGpPWpGaD
Indinavir—CYP2D6—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000989	0.00575	CbGpPWpGaD
Indinavir—CYP2C9—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000981	0.0057	CbGpPWpGaD
Indinavir—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.000935	0.00544	CbGpPWpGaD
Indinavir—SLCO1A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000908	0.00528	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.000896	0.00521	CbGpPWpGaD
Indinavir—ABCC2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000827	0.00481	CbGpPWpGaD
Indinavir—ABCC1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000817	0.00475	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.000789	0.00459	CbGpPWpGaD
Indinavir—SLCO1B1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000776	0.00452	CbGpPWpGaD
Indinavir—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.000716	0.00417	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—AKR1B10—nicotine dependence	0.000696	0.00405	CbGpPWpGaD
Indinavir—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000663	0.00386	CbGpPWpGaD
Indinavir—CYP3A4—Biological oxidations—CYP2A7—nicotine dependence	0.000656	0.00381	CbGpPWpGaD
Indinavir—CYP3A4—Metapathway biotransformation—CYP2A7—nicotine dependence	0.000647	0.00376	CbGpPWpGaD
Indinavir—ABCC1—Disease—AKR1B10—nicotine dependence	0.000492	0.00286	CbGpPWpGaD
Indinavir—SLCO1A2—Metabolism—CYP2A7—nicotine dependence	0.000425	0.00247	CbGpPWpGaD
Indinavir—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000389	0.00226	CbGpPWpGaD
Indinavir—ABCC1—Metabolism—CYP2A7—nicotine dependence	0.000383	0.00223	CbGpPWpGaD
Indinavir—SLCO1B1—Metabolism—CYP2A7—nicotine dependence	0.000364	0.00212	CbGpPWpGaD
Indinavir—CYP3A7—Metabolism—CYP2A7—nicotine dependence	0.000334	0.00194	CbGpPWpGaD
Indinavir—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000311	0.00181	CbGpPWpGaD
Indinavir—CYP3A5—Metabolism—CYP2A7—nicotine dependence	0.000241	0.0014	CbGpPWpGaD
Indinavir—CYP2C19—Metabolism—CYP2A7—nicotine dependence	0.000187	0.00108	CbGpPWpGaD
Indinavir—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000182	0.00106	CbGpPWpGaD
Indinavir—CYP2D6—Metabolism—CYP2A7—nicotine dependence	0.000172	0.000998	CbGpPWpGaD
Indinavir—CYP2C9—Metabolism—CYP2A7—nicotine dependence	0.00017	0.000989	CbGpPWpGaD
Indinavir—CYP3A4—Metabolism—CYP2A7—nicotine dependence	0.000112	0.000652	CbGpPWpGaD
